The global Ebola Virus Vaccine Market, valued at US$ 182.6 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2034, reaching US$ 381.9 million by 2034. Ebola virus disease (EVD), a severe and often fatal hemorrhagic fever, drives demand for vaccines to protect high-risk populations, including healthcare workers and outbreak response team... https://www.transparencymarketresearch.com/ebola-virus-vaccine-market.html